This research highlights the development of a non‐G‐quadruplex, nucleolin‐targeting aptamer TB‐5, which inhibits the invasion, migration, and proliferation of bladder cancer cells by disrupting mRNA transcription processes. This evidence concerns the gene NUCLEOLIN and urinary bladder carcinoma.